Showing results (11-20 of 102) with videos related to
Sort By:
Pageof 11
Oncotarget|June 15, 2017
Cblb-deficient T cells are less susceptible to PD-L1-mediated inhibitionSebastian Peer, Gottfried Baier, Thomas GruberJournal for Immunotherapy of Cancer|June 24, 2025
Potentiation of cancer immunogenicity by targeting PARPDominik Humer, Victoria Klepsch, Gottfried BaierCancers|June 2, 2021
Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6Victoria Klepsch, Kerstin Siegmund, Gottfried BaierImmunology Letters|March 20, 2016
Beyond CTLA-4 and PD-1: Orphan nuclear receptor NR2F6 as T cell signaling switch and emerging target in cancer immunotherapyVictoria Klepsch, Natascha Hermann-Kleiter, Gottfried BaierFrontiers in Immunology|August 14, 2012
Involvement of distinct PKC gene products in T cell functionsChrista Pfeifhofer-Obermair, Nikolaus Thuille, Gottfried BaierImmunology Letters|May 4, 2010
PKCtheta is necessary for efficient activation of NFkappaB, NFAT, and AP-1 during positive selection of thymocytesThomas Gruber, Christa Pfeifhofer-Obermair, Gottfried BaierGenome Biology|March 19, 2002
Molecular genetics and structural genomics of the human protein kinase C gene moduleKurt Kofler, Martin Erdel, Gerd Utermann, et al.Journal of Immunological Methods|October 8, 2020
Chemically modified mRNA nucleofection of primary human T cellsNikolaus Thuille, Tajana Sajinovic, Kerstin Siegmund, et al.Clinical & Developmental Immunology|May 3, 2012
Releasing the brake: targeting Cbl-b to enhance lymphocyte effector functionsStephanie Wallner, Thomas Gruber, Gottfried Baier, et al.Frontiers in Immunology|May 6, 2022
Cerebral Malaria: Current Clinical and Immunological AspectsKarin Albrecht-Schgoer, Peter Lackner, Erich Schmutzhard, et al.Pageof 11